- ►diabetesjournals.org C Droumaguet, B Balkau, D Simon, E Caces, … - Diabetes care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—From the French cohort study Data from an
Epidemiological Study on the Insulin Resistance Syndrome (DESIR), 1,383 men and
1,437 women, aged 30–65 years, were volunteers for a routine health ... Cited by 7 - Related articles - BL Direct - All 5 versions
[CITATION] Exercise or exercise and diet for preventing type 2 diabetes mellitus
D Mauricio, LJ Orozco, AM Buchleitner, G … - Cochrane Database Syst Rev, 2008 Cited by 2 - Related articles
- ►clinchem.org MW Steffes, DB Sacks - Clinical Chemistry, 2005 - Am Assoc Clin Chem Diabetes mellitus was first described in the Egyptian papyrus of Ebers in 1552
BC by people who noted the attraction of insects to the "sweet urine" of those
who produced abnormal amounts and later by tasters of urine who could ... Cited by 8 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org C Stettler, M Stahl, S Allemann, P Diem, K … - Diabetes Care, 2008 - Am Diabetes Assoc We thank Schindhelm et al. (1) for their highly valuable and important comment
referring to our study assessing the association of 1,5-anhydroglucitol (1,5-AG)
with 2-h postprandial blood glucose (2). We fully agree with these authors ... Cited by 7 - Related articles - All 6 versions
HC Pandya, S Livingstone, ME Colgan, IW … - Practical Diabetes International, 1987 - interscience.wiley.com The recent development of the serum fructosamine assay, an indicator of glycated
serum protein, may provide an alternative to glycated haemoglobin (HbA 1 )
measurements. To examine the relationship of serum fructosamine to HbA 1 ... Cited by 7 - Related articles
- ►glycomark.com [PDF] KM Dungan - Expert Review of Molecular Diagnostics, 2008 - ingentaconnect.com 1,5-anhydroglucitol (1,5-AG) is a validated marker of short-term glycemic
control. It is a metabolically inert polyol that competes with glucose for
reabsorption in the kidneys. Otherwise stable levels of 1,5-AG are rapidly ... Cited by 8 - Related articles - BL Direct - All 6 versions
L Nield, CD Summerbell, L Hooper, V … - Cochrane database of systematic reviews (Online), 2008 - ncbi.nlm.nih.gov BACKGROUND: Prevention of type 2 diabetes in adults is a far better option than
treatment, to alleviate pressure on health care providers and resources.
However, there is no current review of the evidence regarding the efficacy ... Cited by 5 - Related articles
H Narbonne, E Renacco, V Pradel, H Portugal, … - Diabetes & metabolism, 2001 - cat.inist.fr Objectifs: Établir si la fructosamine peut être utilisée à la place de
l'HbA 1 c pour déterminer si les objectifs thérapeutiques du diabète
sont atteints quand le dosage de l'HbA 1 c ne peut être utilisée( ... Cited by 12 - Related articles - BL Direct - All 3 versions
JE Howey, WM Bennet, MC Browning, RT … - Diabetic Med, 1989 - interscience.wiley.com Assessment of the relative clinical usefulness of glycosylated haemoglobin (HbA
1 ) and serum fructosamine is complicated by their markedly different
half-lives. They have therefore been compared using a number of indices ... Cited by 12 - Related articles - All 3 versions
RP Robertson, C BOGARDUS - The Journal of laboratory and clinical medicine, 1995 - cat.inist.fr Antagonist: diabetes and insulin resistance: philosophy, science, and the
multiplier hypothesis. Discussion. RP ROBERTSON, C BOGARDUS ... Cited by 6 - Related articles - BL Direct - All 2 versions
